UnitedHealth Group Incorporated $UNH Shares Purchased by Traphagen Investment Advisors LLC

Traphagen Investment Advisors LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 20.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,406 shares of the healthcare conglomerate’s stock after buying an additional 238 shares during the period. Traphagen Investment Advisors LLC’s holdings in UnitedHealth Group were worth $439,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the stock. Winthrop Advisory Group LLC increased its position in UnitedHealth Group by 30.3% in the second quarter. Winthrop Advisory Group LLC now owns 1,545 shares of the healthcare conglomerate’s stock worth $482,000 after buying an additional 359 shares during the period. Puzo Michael J increased its position in UnitedHealth Group by 4.2% in the second quarter. Puzo Michael J now owns 16,653 shares of the healthcare conglomerate’s stock worth $5,195,000 after buying an additional 670 shares during the period. Citizens National Bank Trust Department grew its stake in shares of UnitedHealth Group by 1.8% in the second quarter. Citizens National Bank Trust Department now owns 18,204 shares of the healthcare conglomerate’s stock worth $5,679,000 after purchasing an additional 318 shares in the last quarter. Arcataur Capital Management LLC grew its stake in shares of UnitedHealth Group by 6.1% in the second quarter. Arcataur Capital Management LLC now owns 1,244 shares of the healthcare conglomerate’s stock worth $388,000 after purchasing an additional 72 shares in the last quarter. Finally, Kidder Stephen W grew its stake in shares of UnitedHealth Group by 1.5% in the second quarter. Kidder Stephen W now owns 14,969 shares of the healthcare conglomerate’s stock worth $4,670,000 after purchasing an additional 221 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have recently issued reports on UNH. Morgan Stanley increased their price target on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research note on Friday, September 12th. Cantor Fitzgerald reissued an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Piper Sandler decreased their price target on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research note on Wednesday, July 30th. Truist Financial raised their target price on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Finally, Oppenheimer decreased their target price on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and four have assigned a Sell rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group has an average rating of “Hold” and a consensus target price of $365.00.

UnitedHealth Group Trading Up 1.4%

NYSE:UNH opened at $363.95 on Wednesday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The firm has a market capitalization of $329.62 billion, a price-to-earnings ratio of 15.77, a price-to-earnings-growth ratio of 2.33 and a beta of 0.47. The stock has a fifty day simple moving average of $311.44 and a 200 day simple moving average of $352.42.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same quarter last year, the business earned $6.80 EPS. The company’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.